Please Wait
Applying Filters...
menu
    • menu
    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-03

    Virtual Booth

    An Enquiry

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    An Enquiry

    Menu

    Vebicorvir

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    2D Structure
    Also known as: 2090064-66-5, Vebicorvir [inn], Vebicorvir [usan], Abi-h0731, 16f6055smg, 11-oxo-n-((2-(trifluoromethyl)thiazol-5-yl)methyl)-10,11-dihydrodibenzo[b,f][1,4]thiazepine-8-carboxamide 5,5-dioxide
    Molecular Formula
    C19H12F3N3O4S2
    Molecular Weight
    467.4  g/mol
    InChI Key
    LBJVBJYMZKEREY-UHFFFAOYSA-N
    FDA UNII
    16F6055SMG
    1 2D Structure

    2D Structure

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    6,11,11-trioxo-N-[[2-(trifluoromethyl)-1,3-thiazol-5-yl]methyl]-5H-benzo[b][1,4]benzothiazepine-3-carboxamide
    2.1.2 InChI
    InChI=1S/C19H12F3N3O4S2/c20-19(21,22)18-24-9-11(30-18)8-23-16(26)10-5-6-15-13(7-10)25-17(27)12-3-1-2-4-14(12)31(15,28)29/h1-7,9H,8H2,(H,23,26)(H,25,27)
    2.1.3 InChI Key
    LBJVBJYMZKEREY-UHFFFAOYSA-N
    2.1.4 Canonical SMILES
    C1=CC=C2C(=C1)C(=O)NC3=C(S2(=O)=O)C=CC(=C3)C(=O)NCC4=CN=C(S4)C(F)(F)F
    2.2 Other Identifiers
    2.2.1 UNII
    16F6055SMG
    2.3 Synonyms
    2.3.1 Depositor-Supplied Synonyms

    1. 2090064-66-5

    2. Vebicorvir [inn]

    3. Vebicorvir [usan]

    4. Abi-h0731

    5. 16f6055smg

    6. 11-oxo-n-((2-(trifluoromethyl)thiazol-5-yl)methyl)-10,11-dihydrodibenzo[b,f][1,4]thiazepine-8-carboxamide 5,5-dioxide

    7. 5,5,11-trioxo-10,11-dihydro-5h-dibenzo[b,f][1,4]thiazepine-8-carboxylic Acid (2-trifluoromethyl-thiazol-5-ylmethyl)-amide

    8. Dibenzo(b,f)(1,4)thiazepine-8-carboxamide, 10,11-dihydro-11-oxo-n-((2-(trifluoromethyl)-5-thiazolyl)methyl)-, 5,5-dioxide

    9. Vebicorvir [who-dd]

    10. Unii-16f6055smg

    11. Chembl4650324

    12. Schembl21250344

    13. Who 11201

    14. Hy-109195

    15. Cs-0119137

    16. 11-oxo-n-((2-(trifluoromethyl)thiazol-5-yl)methyl)-10,11-dihydrodibenzo[b,f][1,4]thiazepine-8-carboxamide5,5-dioxide

    17. 5,5,11-trioxo-n-((2-(trifluoromethyl)-1,3-thiazol-5-yl)methyl)-10,11-dihydro-5h- 5.lambda.6-dibenzo(b,f)(1,4)thiazepine-8-carboxamide

    18. 6,11,11-trioxo-n-[[2-(trifluoromethyl)-1,3-thiazol-5-yl]methyl]-5h-benzo[b][1,4]benzothiazepine-3-carboxamide

    2.4 Create Date
    2019-11-02
    3 Chemical and Physical Properties
    Molecular Weight 467.4 g/mol
    Molecular Formula C19H12F3N3O4S2
    XLogP32.4
    Hydrogen Bond Donor Count2
    Hydrogen Bond Acceptor Count9
    Rotatable Bond Count3
    Exact Mass467.02213271 g/mol
    Monoisotopic Mass467.02213271 g/mol
    Topological Polar Surface Area142 Ų
    Heavy Atom Count31
    Formal Charge0
    Complexity817
    Isotope Atom Count0
    Defined Atom Stereocenter Count0
    Undefined Atom Stereocenter Count0
    Defined Bond Stereocenter Count0
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count1